Clinical Trials Logo

Vaso-occlusive Pain Episode clinical trials

View clinical trials related to Vaso-occlusive Pain Episode.

Filter by:
  • None
  • Page 1

NCT ID: NCT02536170 Completed - Sickle Cell Disease Clinical Trials

Arginine Therapy for Sickle Cell Disease Pain

Start date: February 2016
Phase: Phase 2
Study type: Interventional

The aim of this study is to determine whether giving extra arginine, a simple amino acid, to patients with sickle cell disease seeking treatment for a pain crisis (vaso-occlusive painful events (VOE) will decrease pain scores, decrease the need for pain medications or decrease length of hospital stay or emergency department visit. Funding Source - FDA OOPD.